HMGCS2 and diabetic kidney disease: These findings collectively suggest that HMGCS2 overexpression may contribute to DKD pathogenesis, with PRAT‐derived inflammation potentially serving as an early driver of renal injury through tissue‐specific metabolic‐inflammatory crosstalk.